SYDNEY QUERFELD: Open Payments
NPI 1295296879 · GRAND JUNCTION, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$613 in 29 payments from 11 companies in 2025. Trend: 2023 $1,417 · 2024 $1,228 · 2025 $613
Food & beverage: $613
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $181 |
| PFIZER INC. | 6 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $51 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Janssen Biotech, Inc. | 2 | $35 |
| ABC Home Medical Supply, Inc. | 2 | $28 |
| UROGEN PHARMA, INC. | 1 | $26 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $23 |
| Boston Scientific Corporation | 1 | $20 |
Products named: BOTOX, XTANDI, Nubeqa, PYLARIFY, GEMTESA, ERLEADA, LUPRON DEPOT, JELMYTO.
Industry payments across CO — which companies pay providers there.
